-
NPPA warns of artificial shortage of coronary stents
-
Will DBT Work
-
UPL Q3 net profit up 63.32%
-
Korean company files suit against DRL
-
FDA:Natco failed to follow quality control measures
-
Novartis to buy back $5 billion in shares
-
Government fixes prices of 33 essential drugs
-
Natco Pharma did not follow quality control norms:US FDA
-
Natco Pharma did not follow quality control norms:US FDA
-
RSS economic arm frowns on high cost of stents